What did @yerrrjulian actually say?
Julian is approaching one year on Testopel, a subcutaneous testosterone pellet implant, and is about to undergo his fifth insertion procedure. He mentioned that after his last procedure, his testosterone levels came back "pretty high," so his provider is planning to lower the pellet dose next time. He's not claiming pellets are superior for everyone, just sharing his personal experience and framing the page as informational for followers new to this delivery method.
That's a relatively modest set of claims. He's not promising pellets cure anything, not recommending a specific dose, and not telling viewers to switch from injections. Most of what he said is personal narrative, which makes this a lighter fact-check than most HRT content on TikTok.
Does the science back this up?
Yes, mostly. Testosterone pellets are a legitimate, FDA-cleared delivery method. Testopel specifically is approved for hypogonadism in males, and its use in transgender men is an off-label but well-documented clinical practice. The basic pharmacology checks out.
Pellets are implanted subcutaneously, typically in the upper buttock or hip area, and release testosterone slowly over three to six months. Studies like Khera et al. (2012, Journal of Sexual Medicine) have confirmed that pellets can maintain stable serum testosterone levels across that window, which is the main clinical argument for them over weekly or biweekly injections. Julian's comment about his levels running "pretty high" after the procedure is consistent with known pellet pharmacokinetics: levels peak in the first four to six weeks post-insertion and taper from there. Overdosing with pellets is a real, documented problem precisely because you can't remove them easily once inserted.
The five-procedure timeline over roughly one year also lines up with typical clinical practice, where insertions happen every three to four months depending on the patient's response.
What did they get wrong (or right)?
Honestly, Julian got more right than wrong here, at least by omission. He didn't make any wild claims. What's missing from his framing, though, is worth noting for anyone watching this as an informational resource.
He describes pellets as a simple alternative to shots, gels, patches, or pills, but doesn't mention one of the more significant tradeoffs: dosing corrections mid-cycle are essentially impossible. If your levels spike too high, you wait it out. Markarian et al. (2021, Transgender Health) noted that supraphysiologic testosterone levels post-pellet insertion are not uncommon in trans masculine patients, which can cause side effects including acne, mood changes, and erythrocytosis. The fact that Julian himself is getting his dose reduced next procedure suggests this is exactly what happened to him, which is actually useful information, but he glosses over it.
He also doesn't mention that pellet insertion is a minor surgical procedure with real, if low, complication risks including infection, extrusion, and fibrosis at the insertion site. These aren't reasons to avoid pellets, but they're reasons to go in informed.
What should you actually know?
Testopel is a real, regulated option for testosterone therapy, including gender-affirming HRT. It's not a fringe treatment. But "I'm happy with it" from a TikTok creator is not a clinical recommendation, and pellets have specific tradeoffs that don't apply to injections or gels.
The key practical points:
- Pellets release testosterone over roughly three to six months. Levels are not flat, they peak early and decline. This matters for mood, libido, and energy patterns across the cycle.
- Supraphysiologic levels, meaning levels above the normal male range, are more common with pellets than with injections when titration is still being dialed in. Regular labs are non-negotiable, not optional.
- The "no needles" appeal is real, but pellet insertion is still a procedure. It requires a trained provider, a sterile setting, and carries its own risks.
- Cost and insurance coverage for Testopel vary significantly. In some cases, compounded pellets are offered as an alternative. These are not equivalent to FDA-approved Testopel in terms of regulatory oversight, and patients should ask their provider explicitly which product they're receiving.
If you're exploring testosterone delivery options, talk to a provider who manages HRT regularly, not someone who only does occasional insertions. Pellet dosing for trans masculine patients specifically requires experience with that population's response patterns.